B-cell Precursor Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for B-cell Precursor Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2025-10-21FDA Approved: BLINCYTO — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for BLINCYTO (blinatumomab) submitted by Amgen to update the labeling. The change reflects an expand…